Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03238690 · ClinicalTrials.gov registry record · NA
LVAD Conditioning for Cardiac Recovery
A NA study of Heart Failure, sponsored by Stavros G Drakos.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03238690 is a NA study of Heart Failure that is actively recruiting participants, run by Stavros G Drakos. The registered enrollment target is 100 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03238690, a NA study of Heart Failure, is actively recruiting participants, sponsored by Stavros G Drakos.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the potential recovery of heart function in end-stage heart failure patients supported with a Left Ventricular Assist Device (LVAD) through applying a myocardial conditioning protocol. During myocardial conditioning, LVAD speed is reduced gradually in order to increase the work load of the heart. Multiple previous studies have shown that interventions like this may improve heart function and give patients the opportunity for a better quality of life.
Conditions Studied
Interventions
- DEVICE Controlled Cardiac Reloading through LVAD Speed Adjustment
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-06-23 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03238690
The ClinicalTrials.gov registry entry for NCT03238690 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower). The listed sponsor is Stavros G Drakos, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Controlled Cardiac Reloading through LVAD Speed Adjustment is the first listed.
NCT03238690 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT03238690 about?
NCT03238690 is a clinical study titled "LVAD Conditioning for Cardiac Recovery". The purpose of this study is to investigate the potential recovery of heart function in end-stage heart failure patients supported with a Left Ventricular Assist Device (LVAD) through applying a myocardial conditioning protocol. During myocardial conditioning, LVAD speed is reduced gradually in orde...
What is the current status of trial NCT03238690?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2017-06-23. Estimated completion is 2028-06-30.
What conditions does trial NCT03238690 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT03238690?
The interventions under investigation include: Controlled Cardiac Reloading through LVAD Speed Adjustment (DEVICE).
Who is sponsoring clinical trial NCT03238690?
This trial is sponsored by Stavros G Drakos, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03238690 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.